If the patient did not improve and peripheral eosinophilia still persists, we would have planed to perform a bone marrow biopsy and obtain FIP1L1-PDGFR alpha to evaluate bone marrow diseases such as myeloproliferative neoplasms and hypereosinophilic syndrome. This evidence concerns the gene PDGFRA and bone marrow disorder.